Cargando…
Unrelated Donor Usage for Allogeneic HCT in Canada during the First 6 Months of the COVID-19 Pandemic: A Canadian Blood Services Stem Cell Registry Analysis
Autores principales: | Allan, David, Green, Meagan, Morris, Gail, Weiss, Jason T., Dibdin, Nicholas, Mercer, Dena, Elmoazzen, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202740/ http://dx.doi.org/10.1016/S2666-6367(21)00311-0 |
Ejemplares similares
-
Non-Utilization of Cryopreserved Stem Cell Products from Unrelated Donors during the COVID-19 Pandemic
por: Buk, Deborah, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Peripheral Blood Progenitor Cell Collections in Canada
por: Seftel, Matthew, et al.
Publicado: (2023) -
Novel use of percutaneous thrombosuction to rescue the early thrombosis of the conduit vein graft after living donor liver transplantation
por: Jeng, Kuo-Shyang, et al.
Publicado: (2018) -
The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
por: Parmar, Gaganvir, et al.
Publicado: (2023) -
Corneal grafting: what eye care workers need to know
por: Yorston, David, et al.
Publicado: (2009)